MEDICAMEN BIOTECH
Back to Income Statement
|
MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹9.49 Cr | ₹15 Cr | ₹15 Cr | ₹1,212,944 Cr | ₹13 Cr |
What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹9.49 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹1,212,944 Cr |
| Mar2021 | ₹13 Cr |
How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.49 Cr | -35.54 | |
| Mar2024 | ₹15 Cr | -1.13 | |
| Mar2023 | ₹15 Cr | -100.00 | |
| Mar2022 | ₹1,212,944 Cr | 9,125,955.15 | |
| Mar2021 | ₹13 Cr | - | |
Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹413.8 Cr | -3.5% | -2.3% | 1.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,707.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -3.5% |
-2.3% |
1.2% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses